Specify a stock or a cryptocurrency in the search bar to get a summary
Seer Inc
SEERSeer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California. Address: 3800 Bridge Parkway, Redwood City, CA, United States, 94065
Analytics
WallStreet Target Price
3 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures SEER
Dividend Analytics SEER
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History SEER
Stock Valuation SEER
Financials SEER
Results | 2019 | Dynamics |